Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
BrainScan CT
BrainScan CT
BrainScan Inc.
BrainScan automatically detects 20 different brain pathologies on CT to aid prioritization of emergency patients.
Information source:
Vendor
Last updated:
December 8, 2024
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
BrainScan CT
Company
BrainScan Inc.
Subspeciality
Neuro
Modality
CT
Disease targeted
Intracranial/intracerebral/subarachnoid/intraparenchymal hemorrhage, pericerebral/epidural/subdural hematoma, mass lesion, vascular lesions, acute ischemic stroke, malacia, edema, cavity, vascular malformation, atrophy, calcification, cyst, fracture, cerebral contusion
Key-features
Brain pathology detection, hemorrhage detection, localization of pathology
Suggested use
Before: stratifying reading process (non, single, double read), adapting worklist order, flagging acute findings
During: perception aid (prompting all abnormalities/results/heatmaps)
Technical Specifications
Data characteristics
Population
All adult head CT
Input
3D, non-contrast, head CT
Input format
DICOM
Output
Probability scores, heatmap overlays, lesion classification
Output format
DICOM, json
Technology
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis
Automatically, right after the image acquisition
Processing time
10 - 60 seconds
Regulatory
Certification
CE
Certified, Class IIa
, MDR
FDA
No or not yet
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
10-2020
Distribution channels
deepcOS, Aidoc aiOS
Countries present (clinical, non-research use)
1
Paying clinical customers (institutes)
>150
Research/test users (institutes)
1
Pricing
Pricing model
Pay-per-use, Subscription, One-time license fee
Based on
Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers